SERPINF1 and breast cancer: Our findings show for the first time that the mechanisms underlying PEDF anti-metastatic function in BC are differentially governed by not only E2, but also E1 and E1S at levels circulating in pre- and post-menopausal BC patients in a molecular subtype-specific manner.